Please login to the form below

Not currently logged in
Email:
Password:

Array Biopharma

This page shows the latest Array Biopharma news and features for those working in and with pharma, biotech and healthcare.

Merck buys ArQule for $2.7bn in another cancer bolt-on deal

Merck buys ArQule for $2.7bn in another cancer bolt-on deal

Others have included GlaxoSmithKline’s $5.1bn takeover of  Tesaro, Pfizer’s $11.4bn acquisition of  Array Biopharma, Eli Lilly’s  Loxo Oncology deal valued at $8bn and Merck’s

Latest news

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • Deal Watch November 2015 Deal Watch November 2015

    Acquisition - assets. Marketed global dermatology portfolio. 724. Array BioPharma. Pierre Fabre.

  • Deal Watch table for December 2014 Deal Watch table for December 2014

    Exclusive negotiations to create 5-year strategic alliance. 310. Array BioPharma / Oncothyreon. ... ex Japan. original deal headline value. ex US, JP. † If Oncothyreon is acquired with 3 years of effective date, Array eligible for up to $280m milestones

  • Deal Watch table for July 2013 Deal Watch table for July 2013

    485. Array BioPharma / Loxo Oncology. Multi-year licence and collaboration. Drug candidate (preclinical) discovery of small molecule drugs for oncology targets. ... 434. Array BioPharma / Celgene. Collaboration and option. Programme targeting novel

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Array appoints Victor Sandor chief medical officer Array appoints Victor Sandor chief medical officer

    He joins from Incyte and will replace Michael Needle. Array Biopharma has named Victor Sandor as its new chief medical officer, handing him responsibility for leading clinical, medical and regulatory strategy ... Ron Squarer, CEO at Array Biopharma, said:

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics